Clinical trial
Observational Assessment of the Nation-wide Roll-out of Dolutegravir in Lesotho
NCT04238767 is registered in ClinicalTrials.gov with Swiss Tropical & Public Health Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Assessment of the Nation-wide Roll-out of Dolutegravir in Lesotho
- Lead sponsor
- Swiss Tropical & Public Health Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 10, 2020
- Completion date
- May 20, 2021
- Enrollment
- 1,433 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1-infection